Biostar Pharmaceuticals, Inc. Short-term Debt
Biostar Pharmaceuticals, Inc. had Short-term Debt of CNY 20.00 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Short-Term Debt
us-gaap:ShortTermBorrowings · last filed 2017-11-20
- 2017-09-30: Short-term Debt 20.00M CNY.
- 2017-06-30: Short-term Debt 20.00M CNY.
- 2017-03-31: Short-term Debt 20.00M CNY.
- 2016-12-31: Short-term Debt 20.00M CNY.
CNY
| Period end | Short-term Debt |
|---|---|
| 2017-09-30 | 20.00M CNY 10-Q · filed 2017-11-20 |
| 2017-06-30 | 20.00M CNY 10-Q · filed 2017-11-15 |
| 2017-03-31 | 20.00M CNY 10-Q · filed 2017-05-19 |
| 2016-12-31 | 20.00M CNY 10-Q · filed 2017-11-20 |
| 2016-09-30 | 20.00M CNY 10-Q · filed 2016-11-21 |
| 2016-06-30 | 20.00M CNY 10-Q · filed 2016-08-22 |
| 2016-03-31 | 20.00M CNY 10-Q · filed 2016-05-23 |
| 2015-12-31 | 20.00M CNY 10-K · filed 2017-04-13 |
| 2015-09-30 | 20.00M CNY 10-Q · filed 2015-11-23 |
| 2015-06-30 | 20.00M CNY 10-Q · filed 2015-08-19 |
| 2014-12-31 | 20.00M CNY 10-K · filed 2016-04-14 |
USD
| Period end | Short-term Debt |
|---|---|
| 2017-09-30 | $2.43M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $2.38M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $2.34M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $2.33M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $2.42M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $2.43M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $2.50M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $2.77M 10-K · filed 2017-04-13 |
| 2015-09-30 | $2.81M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $2.93M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $2.95M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $3.09M 10-K · filed 2016-04-14 |
| 2014-09-30 | $3.25M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $3.25M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-04-15 |
| 2013-09-30 | $4.88M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $4.85M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $4.78M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $4.76M 10-K · filed 2014-03-31 |
| 2011-12-31 | $787.12K 10-K · filed 2013-04-15 |